iRhythm Technologies Feed

	Est. tid*
2026-05-04	22:10	Kvartalsrapport 2026-Q1
2026-02-23	N/A	Bokslutskommuniké 2025
2025-11-03	22:10	Kvartalsrapport 2025-Q3
2025-08-04	22:10	Kvartalsrapport 2025-Q2
2025-05-28	-	Årsstämma
2025-05-02	-	Kvartalsrapport 2025-Q1
2025-02-21	-	Bokslutskommuniké 2024
2024-10-31	-	Kvartalsrapport 2024-Q3
2024-08-02	-	Kvartalsrapport 2024-Q2
2024-05-29	-	Årsstämma
2024-05-03	-	Kvartalsrapport 2024-Q1
2024-02-23	-	Bokslutskommuniké 2023
2023-11-03	-	Kvartalsrapport 2023-Q3
2023-08-04	-	Kvartalsrapport 2023-Q2
2023-05-24	-	Årsstämma
2023-05-05	-	Kvartalsrapport 2023-Q1
2023-02-23	-	Bokslutskommuniké 2022
2022-11-04	-	Kvartalsrapport 2022-Q3
2022-08-05	-	Kvartalsrapport 2022-Q2
2022-05-26	-	Årsstämma
2022-05-06	-	Kvartalsrapport 2022-Q1
2022-02-28	-	Bokslutskommuniké 2021
2021-11-05	-	Kvartalsrapport 2021-Q3
2021-08-09	-	Kvartalsrapport 2021-Q2
2021-06-18	-	Årsstämma
2021-05-10	-	Kvartalsrapport 2021-Q1
2021-02-26	-	Bokslutskommuniké 2020
2020-11-06	-	Kvartalsrapport 2020-Q3
2020-08-07	-	Kvartalsrapport 2020-Q2
2020-06-19	-	Årsstämma
2020-05-08	-	Kvartalsrapport 2020-Q1
2019-07-31	-	Kvartalsrapport 2019-Q2
2019-05-22	-	Årsstämma
2019-05-07	-	Kvartalsrapport 2019-Q1

2025-07-31 22:10:00 iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions 166,00 USD | +19,45%

2025-07-31 22:05:00 iRhythm Technologies Announces Second Quarter 2025 Financial Results 166,00 USD | +19,45%

2025-07-17 22:30:00 iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025 136,62 USD | -0,82%

2025-07-07 14:30:00 iRhythm Technologies Announces Board Member Retirements and New Director Appointments 141,53 USD | -0,65%

2025-06-23 14:30:00 New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease 148,84 USD | +2,40%

2025-05-21 22:45:00 iRhythm Technologies to Participate in Upcoming Investor Conferences 141,74 USD | -0,63%

2025-05-01 22:10:00 iRhythmは、日本においてZio ECG記録・解析システムとしてZio®長期連続モニタリング　サービスを開始し、AIを活用した不整脈検出の進化を推進します。 131,48 USD | +22,76%

2025-05-01 22:10:00 iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection 131,48 USD | +22,76%

2025-04-30 00:05:00 iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

2025-04-28 14:05:00 iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring 108,27 USD | +2,17%

2025-04-17 22:30:00 iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 101,77 USD | +0,17%

2025-04-16 14:35:00 iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability 101,60 USD | +0,91%

2025-03-31 14:05:00 iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection 102,75 USD | -1,68%

2025-02-20 22:05:00 iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results 119,78 USD | +6,53%

2025-02-06 22:05:00 iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 108,75 USD | -0,50%

2025-01-13 14:30:00 iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference 94,00 USD | +2,20%

2024-12-30 22:30:00 iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference 88,72 USD | +2,54%

2024-11-20 22:30:00 iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference 74,36 USD | +0,46%

2024-11-18 14:15:00 iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring 78,95 USD | -2,54%

2024-11-05 22:30:00 iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference 90,60 USD | +3,41%

2024-10-30 22:15:08 iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device 74,07 USD | -2,96%

2024-10-30 21:08:07 iRhythm Technologies Announces Third Quarter 2024 Financial Results 74,07 USD | -2,96%

2024-10-28 13:02:00 Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy 75,77 USD | -1,37%

2024-10-21 22:05:28 iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device 75,22 USD | +23,28%

2024-10-16 22:05:00 iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024 63,58 USD | +4,40%

2024-09-11 14:05:00 iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence 73,52 USD | +2,47%

2024-09-09 14:05:00 iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting 68,44 USD | +6,59%

2024-09-04 13:30:00 iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring 70,48 USD | +2,97%

2024-09-01 19:33:00 iRhythm Technologies Announces Results of GUARD-AF Trial

2024-08-29 14:00:00 iRhythm Technologies amplia la portata globale con il lancio del servizio di monitoraggio dell’aritmia cardiaca Zio® in Austria, Paesi Bassi, Svizzera e Spagna 74,89 USD | +9,33%

2024-08-29 14:00:00 iRhythm Technologies élargit sa portée mondiale avec le lancement, en Autriche, aux Pays-Bas, en Suisse et en Espagne, du service de surveillance de l’arythmie cardiaque Zio® 74,89 USD | +9,33%

2024-08-29 14:00:00 iRhythm Technologies erweitert seine globale Reichweite mit der Einführung des Zio®-Dienstes zur Überwachung von Herzrhythmusstörungen (Cardiac Arrhythmia Monitoring Service) in den Niederlanden, Österreich, der Schweiz und Spanien 74,89 USD | +9,33%

2024-08-29 14:00:00 iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain 74,89 USD | +9,33%

2024-08-29 14:00:00 iRhythm Technologies amplía el alcance global con el lanzamiento del servicio de monitorización de arritmias cardíacas Zio® en Austria, España, Países Bajos y Suiza 74,89 USD | +9,33%

2024-08-29 14:00:00 iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain 74,89 USD | +9,33%

2024-08-29 14:00:00 iRhythm Technologies breidt uit in Oostenrijk, Nederland, Zwitserland en Spanje met Zio® monitor hartritmestoornismonitoring 74,89 USD | +9,33%

2024-08-29 14:00:00 iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain 74,89 USD | +9,33%

2024-08-21 22:05:00 iRhythm Technologies to Participate in Upcoming Investor Conferences in September 69,32 USD | -1,07%

2024-08-01 22:06:00 iRhythm Technologies Announces Chief Financial Officer Transition 72,50 USD | -14,58%

2024-07-18 22:05:00 iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024 96,42 USD | -3,18%

2024-06-17 22:05:00 iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation 100,11 USD | +4,67%

2024-06-04 22:05:00 iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference 88,57 USD | +5,13%

2024-05-22 22:05:00 iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference 89,23 USD | -1,18%

2024-04-18 22:05:00 iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024 112,39 USD | -0,29%

2024-03-08 22:30:01 iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes 108,13 USD | 0,00%

2024-03-05 05:42:45 iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029 109,18 USD | 0,00%

2024-03-04 12:45:11 iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes 109,18 USD | -8,31%

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

iRhythm Technologies

Kalender

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden